SAN DIEGO--(BUSINESS WIRE)--Robbins Geller Rudman & Dowd LLP announces that purchasers of Sesen Bio, Inc. (NASDAQ: SESN) securities between December 21, 2020 and August 17, 2021, inclusive (the “Class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results